Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fidelma Dunne

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
American Journal of Obstetrics & Gynecology MFM|March 9, 2024
The IRELAnD study-investigating the role of early low-dose aspirin in diabetes mellitus: a double-blinded, placebo-controlled, randomized trialCatherine Finnegan, Patrick Dicker, Denisa Asandei, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trialElisabeth R Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy, et al.
Diabetes Research and Clinical Practice|August 4, 2025
Low prolactin levels as a marker of gestational diabetes in late pregnancyRoberta Scairati, Renata S Auriemma, Sara Di Meglio, et al.
JAMA|October 3, 2023
Early Metformin in Gestational Diabetes: A Randomized Clinical TrialFidelma Dunne, Christine Newman, Alberto Alvarez-Iglesias, et al.
Diabetes Care|July 31, 2021
Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE StudyElisabeth R Mathiesen, Norsiah Ali, Amra C Alibegovic, et al.
Diabetes|March 29, 2003
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gammaDavid B Savage, Garry D Tan, Carlo L Acerini, et al.
Nutrients|August 26, 2022
The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI StudyLilian Cristina Mendoza, Jürgen Harreiter, Gernot Desoye, et al.
Current Diabetes Reports|June 23, 2020
Correction to: The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have we Learned from the DALI Studies?Jürgen Harreiter, Gernot Desoye, Mireille N M van Poppel, et al.
Obstetrics and Gynecology|July 12, 2018
Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases WorkshopDeborah J Wexler, Camille E Powe, Linda A Barbour, et al.
Current Diabetes Reports|December 18, 2019
The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have We Learned from the DALI Studies?Jürgen Harreiter, Gernot Desoye, Mireille N M van Poppel, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
American Journal of Obstetrics & Gynecology MFM|March 9, 2024
The IRELAnD study-investigating the role of early low-dose aspirin in diabetes mellitus: a double-blinded, placebo-controlled, randomized trialCatherine Finnegan, Patrick Dicker, Denisa Asandei, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trialElisabeth R Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy, et al.
Diabetes Research and Clinical Practice|August 4, 2025
Low prolactin levels as a marker of gestational diabetes in late pregnancyRoberta Scairati, Renata S Auriemma, Sara Di Meglio, et al.
JAMA|October 3, 2023
Early Metformin in Gestational Diabetes: A Randomized Clinical TrialFidelma Dunne, Christine Newman, Alberto Alvarez-Iglesias, et al.
Diabetes Care|July 31, 2021
Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE StudyElisabeth R Mathiesen, Norsiah Ali, Amra C Alibegovic, et al.
Diabetes|March 29, 2003
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gammaDavid B Savage, Garry D Tan, Carlo L Acerini, et al.
Nutrients|August 26, 2022
The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI StudyLilian Cristina Mendoza, Jürgen Harreiter, Gernot Desoye, et al.
Current Diabetes Reports|June 23, 2020
Correction to: The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have we Learned from the DALI Studies?Jürgen Harreiter, Gernot Desoye, Mireille N M van Poppel, et al.
Obstetrics and Gynecology|July 12, 2018
Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases WorkshopDeborah J Wexler, Camille E Powe, Linda A Barbour, et al.
Current Diabetes Reports|December 18, 2019
The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have We Learned from the DALI Studies?Jürgen Harreiter, Gernot Desoye, Mireille N M van Poppel, et al.
Pageof 9